AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines

The utility of AsCas12a can be limited to poor editing efficiency. Here the authors identify a variant, “AsCas12a Ultra”, that has high on-target specificity demonstrated through editing of clinically relevant T cell genes.

Saved in:
Bibliographic Details
Main Authors: Liyang Zhang, John A. Zuris, Ramya Viswanathan, Jasmine N. Edelstein, Rolf Turk, Bernice Thommandru, H. Tomas Rube, Steve E. Glenn, Michael A. Collingwood, Nicole M. Bode, Sarah F. Beaudoin, Swarali Lele, Sean N. Scott, Kevin M. Wasko, Steven Sexton, Christopher M. Borges, Mollie S. Schubert, Gavin L. Kurgan, Matthew S. McNeill, Cecilia A. Fernandez, Vic E. Myer, Richard A. Morgan, Mark A. Behlke, Christopher A. Vakulskas
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
Q
Online Access:https://doaj.org/article/0168163683a24415a8a5f32e5a19e09a
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:doaj.org-article:0168163683a24415a8a5f32e5a19e09a
record_format dspace
spelling oai:doaj.org-article:0168163683a24415a8a5f32e5a19e09a2021-12-02T18:02:47ZAsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines10.1038/s41467-021-24017-82041-1723https://doaj.org/article/0168163683a24415a8a5f32e5a19e09a2021-06-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-24017-8https://doaj.org/toc/2041-1723The utility of AsCas12a can be limited to poor editing efficiency. Here the authors identify a variant, “AsCas12a Ultra”, that has high on-target specificity demonstrated through editing of clinically relevant T cell genes.Liyang ZhangJohn A. ZurisRamya ViswanathanJasmine N. EdelsteinRolf TurkBernice ThommandruH. Tomas RubeSteve E. GlennMichael A. CollingwoodNicole M. BodeSarah F. BeaudoinSwarali LeleSean N. ScottKevin M. WaskoSteven SextonChristopher M. BorgesMollie S. SchubertGavin L. KurganMatthew S. McNeillCecilia A. FernandezVic E. MyerRichard A. MorganMark A. BehlkeChristopher A. VakulskasNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-15 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Liyang Zhang
John A. Zuris
Ramya Viswanathan
Jasmine N. Edelstein
Rolf Turk
Bernice Thommandru
H. Tomas Rube
Steve E. Glenn
Michael A. Collingwood
Nicole M. Bode
Sarah F. Beaudoin
Swarali Lele
Sean N. Scott
Kevin M. Wasko
Steven Sexton
Christopher M. Borges
Mollie S. Schubert
Gavin L. Kurgan
Matthew S. McNeill
Cecilia A. Fernandez
Vic E. Myer
Richard A. Morgan
Mark A. Behlke
Christopher A. Vakulskas
AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines
description The utility of AsCas12a can be limited to poor editing efficiency. Here the authors identify a variant, “AsCas12a Ultra”, that has high on-target specificity demonstrated through editing of clinically relevant T cell genes.
format article
author Liyang Zhang
John A. Zuris
Ramya Viswanathan
Jasmine N. Edelstein
Rolf Turk
Bernice Thommandru
H. Tomas Rube
Steve E. Glenn
Michael A. Collingwood
Nicole M. Bode
Sarah F. Beaudoin
Swarali Lele
Sean N. Scott
Kevin M. Wasko
Steven Sexton
Christopher M. Borges
Mollie S. Schubert
Gavin L. Kurgan
Matthew S. McNeill
Cecilia A. Fernandez
Vic E. Myer
Richard A. Morgan
Mark A. Behlke
Christopher A. Vakulskas
author_facet Liyang Zhang
John A. Zuris
Ramya Viswanathan
Jasmine N. Edelstein
Rolf Turk
Bernice Thommandru
H. Tomas Rube
Steve E. Glenn
Michael A. Collingwood
Nicole M. Bode
Sarah F. Beaudoin
Swarali Lele
Sean N. Scott
Kevin M. Wasko
Steven Sexton
Christopher M. Borges
Mollie S. Schubert
Gavin L. Kurgan
Matthew S. McNeill
Cecilia A. Fernandez
Vic E. Myer
Richard A. Morgan
Mark A. Behlke
Christopher A. Vakulskas
author_sort Liyang Zhang
title AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines
title_short AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines
title_full AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines
title_fullStr AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines
title_full_unstemmed AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines
title_sort ascas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/0168163683a24415a8a5f32e5a19e09a
work_keys_str_mv AT liyangzhang ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines
AT johnazuris ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines
AT ramyaviswanathan ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines
AT jasminenedelstein ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines
AT rolfturk ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines
AT bernicethommandru ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines
AT htomasrube ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines
AT steveeglenn ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines
AT michaelacollingwood ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines
AT nicolembode ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines
AT sarahfbeaudoin ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines
AT swaralilele ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines
AT seannscott ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines
AT kevinmwasko ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines
AT stevensexton ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines
AT christophermborges ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines
AT molliesschubert ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines
AT gavinlkurgan ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines
AT matthewsmcneill ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines
AT ceciliaafernandez ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines
AT vicemyer ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines
AT richardamorgan ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines
AT markabehlke ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines
AT christopheravakulskas ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines
_version_ 1718378847708119040